Search Results 31-40 of 4802 for 搜索留痕平台咨询邮箱：lgooxc@hotmail.com

  1. https://www.mayoclinic.org/~/media/0439A7376021433E8FB3180F95C8FF95

  2. Consultative resources - Center for Clinical and Translational Science

    Find consultative resources and support services for Mayo Clinic investigators and study teams at the Center for Clinical and Translational Science (CCaTS).

  4. Lifeng Yu, Ph.D. - Mayo Clinic Faculty Profiles

    Mayo Clinic researcher Lifeng Yu, Ph.D., focuses on the clinical applications of X-ray CT physics. This includes radiation dose optimization, image quality ...

  5. Search tips - Clinical Trials - Mayo Clinic Research

    Search tips. Browsing versus searching. The browse feature of the website relies on the categorization of trials by diseases and conditions or procedures.

  6. Epidemiology of Chronic Lymphocytic Leukemia Study - B-Cell Lymphoproliferative Disorders - Mayo Clinic Research

    The Epidemiology of Chronic Lymphocytic Leukemia study is research led by Dr. Susan Slager at Mayo Clinic to identify new genes that are responsible for CLL ...

  7. https://www.mayoclinic.org/~/media/FD382661FD544C6CB4A38FC785855FAB

  8. Hmong intro

    Cov lus nug hauv qab no yog ib feem ntawm Kev Kuaj Nrhiav Kev Nyuaj Siab. Cov lus teb yuav pab koj tus kws saib xyuas kho mob los txheeb xyuas thaj chaw uas ...

  9. For Our Affiliates - Mayo Clinic News Network

    This content is password protected. To view it please enter your password below: Password: About the News Network · Newsbureau@mayo.edu.

  10. Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL) - Mayo Clinic

    Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With ...